n-methylaspartate has been researched along with Psychotic Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Artigas, F; Castañé, A; Castarlenas, L; Fabius, S; López-Hill, X; Miquel-Rio, L; Santana, N; Scorza, MC; Tarrés-Gatius, M; Vilaró, MT | 1 |
| Dahlén, A; Guo, S; Melgoza, A; Wagle, M; Zarei, M | 1 |
| Cleland, N; Lieblich, S; Rahm, C; Schalling, M | 1 |
| Herman, L; Peter, L; Rethelyi, JM; Zsigmond, IR | 1 |
| Litvinenko, IV | 1 |
| Gourevitch, R | 1 |
| Sachdev, PS | 1 |
| Cannizzaro, C; Cannizzaro, G; Flugy, A; Gagliand, M; Mineo, A; Sabatino, M | 1 |
| de Montigny, C; Debonnel, G | 1 |
| Bogerts, B; Böker, H; Danos, P; Lins, H; Northoff, G | 1 |
| Bingmann, D; Düsing, R; Grunze, H; Liu, Z; Walden, J | 1 |
4 review(s) available for n-methylaspartate and Psychotic Disorders
| Article | Year |
|---|---|
[Review of the psychiatric aspects of anti-NMDA (N-methyl-D-aspartic acid) receptor encephalitis, case report, and our plans for a future study].
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Humans; Limbic Encephalitis; N-Methylaspartate; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate | 2016 |
[Dementia and psychotic disorders in parkinsonism: common origin and new perspectives in therapy].
Topics: Dementia; Humans; N-Methylaspartate; Neurotransmitter Agents; Parkinson Disease; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate | 2004 |
Alternating and postictal psychoses: review and a unifying hypothesis.
Topics: Brain; Electroencephalography; Epilepsy; gamma-Aminobutyric Acid; Humans; N-Methylaspartate; Psychotic Disorders; Schizophrenia | 2007 |
Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.
Topics: Animals; Central Nervous System; Dopamine; Humans; Mental Disorders; N-Methylaspartate; Neuropeptides; Phencyclidine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Steroids; Synaptic Transmission | 1996 |
7 other study(ies) available for n-methylaspartate and Psychotic Disorders
| Article | Year |
|---|---|
Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models.
Topics: Animals; Dizocilpine Maleate; GABAergic Neurons; Mice; Mice, Knockout; N-Methylaspartate; Phencyclidine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate | 2022 |
THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dronabinol; N-Methylaspartate; Piperidines; Psychotic Disorders; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Stereotyped Behavior; Zebrafish | 2021 |
A 16-year-old girl with anti-NMDA-receptor encephalitis and family history of psychotic disorders.
Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Female; Humans; Memory, Long-Term; N-Methylaspartate; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate | 2015 |
[Neurobiological aspects of bipolar disorder].
Topics: Amygdala; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cognition Disorders; Diagnosis, Differential; Hippocampus; Humans; N-Methylaspartate; Neuropsychological Tests; Prefrontal Cortex; Psychotic Disorders; Schizophrenia | 2005 |
NMDA-GABA interactions in an animal model of behaviour: a gating mechanism from motivation toward psychotic-like symptoms.
Topics: Alprazolam; Animals; Behavior, Animal; Desipramine; Disease Models, Animal; Dizocilpine Maleate; gamma-Aminobutyric Acid; Kindling, Neurologic; Male; Motivation; Motor Activity; Muscimol; N-Methylaspartate; Pentylenetetrazole; Psychotic Disorders; Rats; Rats, Wistar; Swimming | 1994 |
Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia.
Topics: Adult; Amantadine; Bipolar Disorder; Catatonia; Dopamine Agents; Excitatory Amino Acid Agonists; Fever; Humans; Male; N-Methylaspartate; Psychotic Disorders | 1999 |
Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies.
Topics: Animals; Calcium Channel Blockers; Carbamazepine; Epilepsy; Extracellular Space; Guinea Pigs; Hippocampus; In Vitro Techniques; Magnesium; Microelectrodes; N-Methylaspartate; Psychotic Disorders; Verapamil | 1992 |